SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-161170
Filing Date
2024-06-14
Accepted
2024-06-14 07:36:01
Documents
72
Period of Report
2024-06-14
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d826950d8k.htm   iXBRL 8-K 47835
2 EX-99.1 d826950dex991.htm EX-99.1 30506
3 EX-99.2 d826950dex992.htm EX-99.2 60567
7 GRAPHIC g826950dsp06.jpg GRAPHIC 5517
8 GRAPHIC g826950ex99_2p10g1.jpg GRAPHIC 267547
9 GRAPHIC g826950ex99_2p11g1.jpg GRAPHIC 204864
10 GRAPHIC g826950ex99_2p12g1.jpg GRAPHIC 205615
11 GRAPHIC g826950ex99_2p13g1.jpg GRAPHIC 122583
12 GRAPHIC g826950ex99_2p14g1.jpg GRAPHIC 178385
13 GRAPHIC g826950ex99_2p15g1.jpg GRAPHIC 194892
14 GRAPHIC g826950ex99_2p16g1.jpg GRAPHIC 181059
15 GRAPHIC g826950ex99_2p17g1.jpg GRAPHIC 224735
16 GRAPHIC g826950ex99_2p18g1.jpg GRAPHIC 151188
17 GRAPHIC g826950ex99_2p19g1.jpg GRAPHIC 208224
18 GRAPHIC g826950ex99_2p1g1.jpg GRAPHIC 119124
19 GRAPHIC g826950ex99_2p20g1.jpg GRAPHIC 249193
20 GRAPHIC g826950ex99_2p21g1.jpg GRAPHIC 237542
21 GRAPHIC g826950ex99_2p22g1.jpg GRAPHIC 248306
22 GRAPHIC g826950ex99_2p23g1.jpg GRAPHIC 183737
23 GRAPHIC g826950ex99_2p24g1.jpg GRAPHIC 216540
24 GRAPHIC g826950ex99_2p25g1.jpg GRAPHIC 219803
25 GRAPHIC g826950ex99_2p26g1.jpg GRAPHIC 98738
26 GRAPHIC g826950ex99_2p27g1.jpg GRAPHIC 195943
27 GRAPHIC g826950ex99_2p28g1.jpg GRAPHIC 229677
28 GRAPHIC g826950ex99_2p29g1.jpg GRAPHIC 276960
29 GRAPHIC g826950ex99_2p2g1.jpg GRAPHIC 586923
30 GRAPHIC g826950ex99_2p30g1.jpg GRAPHIC 212991
31 GRAPHIC g826950ex99_2p31g1.jpg GRAPHIC 287513
32 GRAPHIC g826950ex99_2p32g1.jpg GRAPHIC 277544
33 GRAPHIC g826950ex99_2p33g1.jpg GRAPHIC 194888
34 GRAPHIC g826950ex99_2p34g1.jpg GRAPHIC 199170
35 GRAPHIC g826950ex99_2p35g1.jpg GRAPHIC 192141
36 GRAPHIC g826950ex99_2p36g1.jpg GRAPHIC 98751
37 GRAPHIC g826950ex99_2p37g1.jpg GRAPHIC 175589
38 GRAPHIC g826950ex99_2p38g1.jpg GRAPHIC 180900
39 GRAPHIC g826950ex99_2p39g1.jpg GRAPHIC 143023
40 GRAPHIC g826950ex99_2p3g1.jpg GRAPHIC 70951
41 GRAPHIC g826950ex99_2p40g1.jpg GRAPHIC 221952
42 GRAPHIC g826950ex99_2p41g1.jpg GRAPHIC 213276
43 GRAPHIC g826950ex99_2p42g1.jpg GRAPHIC 253693
44 GRAPHIC g826950ex99_2p43g1.jpg GRAPHIC 215307
45 GRAPHIC g826950ex99_2p44g1.jpg GRAPHIC 154933
46 GRAPHIC g826950ex99_2p45g1.jpg GRAPHIC 189475
47 GRAPHIC g826950ex99_2p46g1.jpg GRAPHIC 97243
48 GRAPHIC g826950ex99_2p47g1.jpg GRAPHIC 216659
49 GRAPHIC g826950ex99_2p48g1.jpg GRAPHIC 209863
50 GRAPHIC g826950ex99_2p49g1.jpg GRAPHIC 96590
51 GRAPHIC g826950ex99_2p4g1.jpg GRAPHIC 98165
52 GRAPHIC g826950ex99_2p50g1.jpg GRAPHIC 54499
53 GRAPHIC g826950ex99_2p51g1.jpg GRAPHIC 178473
54 GRAPHIC g826950ex99_2p52g1.jpg GRAPHIC 137129
55 GRAPHIC g826950ex99_2p53g1.jpg GRAPHIC 216693
56 GRAPHIC g826950ex99_2p54g1.jpg GRAPHIC 170585
57 GRAPHIC g826950ex99_2p55g1.jpg GRAPHIC 208141
58 GRAPHIC g826950ex99_2p56g1.jpg GRAPHIC 161659
59 GRAPHIC g826950ex99_2p5g1.jpg GRAPHIC 222456
60 GRAPHIC g826950ex99_2p6g1.jpg GRAPHIC 201041
61 GRAPHIC g826950ex99_2p7g1.jpg GRAPHIC 180873
62 GRAPHIC g826950ex99_2p8g1.jpg GRAPHIC 98301
63 GRAPHIC g826950ex99_2p9g1.jpg GRAPHIC 204254
  Complete submission text file 0001193125-24-161170.txt   15236769

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA iron-20240614.xsd EX-101.SCH 2866
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE iron-20240614_lab.xml EX-101.LAB 18738
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE iron-20240614_pre.xml EX-101.PRE 11718
75 EXTRACTED XBRL INSTANCE DOCUMENT d826950d8k_htm.xml XML 3765
Mailing Address 321 ARSENAL STREET, SUITE 101 WATERTOWN MA 02472
Business Address 321 ARSENAL STREET, SUITE 101 WATERTOWN MA 02472 (617) 674-9274
Disc Medicine, Inc. (Filer) CIK: 0001816736 (see all company filings)

IRS No.: 851613057 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39438 | Film No.: 241043157
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)